treatment of sarcoid patients with corticosteroids , a therapy known to suppress the activity of the disease , caused a marked reduction in the level of spontaneous ifn gamma release by lung mononuclear cells compared with untreated patients ( p less than 0.02 ) , which suggests that the effectiveness of corticosteroid therapy in controlling active pulmonary sarcoidosis may , at least in part , be due to suppression of ifn gamma release .
C0024109
lung
C0036205
pulmonary sarcoidosis